COVID-19: Berlin scientists lay basis for a passive vaccination

Researchers have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also discovered that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects.

from Top Health News -- ScienceDaily https://ift.tt/3i1Kwr6